Literature DB >> 19444395

[Malignant melanoma].

J Göhl1, W Hohenberger, S Merkel.   

Abstract

Malignant melanomas have one of the highest increases in incidence among malignancies. There are four histological types: superficial spreading melanoma, nodular melanoma, acrolentiginous melanoma and lentigo maligna melanoma. The TNM classification considers depth of infiltration (Clark's level), vertical tumor thickness (Breslow's thickness), ulceration of the primary tumor, satellites and in-transit metastases as well as regional lymph node and distant metastases. An adequate margin of clearance is important in primary resection. Sentinel lymph node biopsy is relevant in all melanomas with a Breslow tumor thickness >1 mm without clinically suspicious lymph nodes. In the case of lymph node metastases therapeutic dissection is recommended, in patients with in-transit metastases of the extremities hyperthermic isolated limb perfusion with cytostatic agents may be indicated. Resection of distant metastases can be useful if only one site is affected or a R0 resection is expected to be achieved. Adjuvant, neoadjuvant and palliative procedures, such as radiotherapy, chemotherapy and immunotherapy are additional treatment options.

Entities:  

Mesh:

Year:  2009        PMID: 19444395     DOI: 10.1007/s00104-009-1711-2

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  10 in total

1.  Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.

Authors:  Esther de Vries; Freddie I Bray; Jan Willem W Coebergh; Donald M Parkin
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

2.  Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.

Authors:  M H Seegenschmiedt; L Keilholz; A Altendorf-Hofmann; A Urban; H Schell; W Hohenberger; R Sauer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-06-01       Impact factor: 7.038

3.  Surgical therapy for distant metastases of malignant melanoma.

Authors:  T Meyer; S Merkel; J Goehl; W Hohenberger
Journal:  Cancer       Date:  2000-11-01       Impact factor: 6.860

4.  High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.

Authors:  J M Kirkwood; J G Ibrahim; J A Sosman; V K Sondak; S S Agarwala; M S Ernstoff; U Rao
Journal:  J Clin Oncol       Date:  2001-05-01       Impact factor: 44.544

Review 5.  Epidemiology of cutaneous melanoma in Germany and worldwide.

Authors:  C Garbe; A Blum
Journal:  Skin Pharmacol Appl Skin Physiol       Date:  2001 Sep-Oct

6.  Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.

Authors:  Hobart W Walling; Richard K Scupham; Andrew K Bean; Roger I Ceilley
Journal:  J Am Acad Dermatol       Date:  2007-10       Impact factor: 11.527

Review 7.  Extracutaneous malignant melanomas.

Authors:  Mahmoud R Hussein
Journal:  Cancer Invest       Date:  2008-06       Impact factor: 2.176

Review 8.  Next generation of immunotherapy for melanoma.

Authors:  John M Kirkwood; Ahmad A Tarhini; Monica C Panelli; Stergios J Moschos; Hassane M Zarour; Lisa H Butterfield; Helen J Gogas
Journal:  J Clin Oncol       Date:  2008-07-10       Impact factor: 44.544

9.  "Functional" surgery in subungual melanoma.

Authors:  Matthias Moehrle; Silke Metzger; Wilfried Schippert; Claus Garbe; Gernot Rassner; Helmut Breuninger
Journal:  Dermatol Surg       Date:  2003-04       Impact factor: 3.398

10.  Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

Authors:  Beatrice Schuler-Thurner; Erwin S Schultz; Thomas G Berger; Georg Weinlich; Susanne Ebner; Petra Woerl; Armin Bender; Bernadette Feuerstein; Peter O Fritsch; Nikolaus Romani; Gerold Schuler
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

  10 in total
  1 in total

1.  [Exophytic tumor of the neck].

Authors:  J Linke; M Neudert; A Forberger; T Zahnert
Journal:  HNO       Date:  2012-10       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.